EUVIMEDOpdag EUVIMED
Crossref

Identification of BAY61 ‐3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation

Takanori Matsumaru, Toshiki Iwamatsu, Kana Ishigami, Makoto Inai, Wataru Kanto, Ayumi Ishigaki, Atsushi Toyoda, Satoshi Shuto, Katsumi Maenaka, Shinichi Nakagawa, Hiroshi Maita iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.70002 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Takanori Matsumaru and 10 co-authors. Institution: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan. Major MEDLINE topics: Exons, RNA Splicing Factors, RNA Splicing, Mutation. 54 references. Funded by: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science London.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Splicing modulation by a small compound offers therapeutic potential for diseases caused by splicing abnormality. However, only a few classes of compounds that can modulate splicing have been identified. We previously identified BAY61‐3606, a multiple kinase inhibitor, as a compound that relaxes the splicing fidelity at the 3′ splice site recognition. We have also reported the synthesis of derivatives of BAY61‐3606. In this study, we tested those compounds for their splicing modulation capabilities and identified two contrasting compounds. These compounds were further investigated for their effects on the whole transcriptome, and analysis of changes in transcription and splicing revealed that the highly active derivative in the splicing reporter assay also showed significantly higher activity in modulating the splicing of endogenously expressed genes. Particularly, cassette exon inclusion was highly upregulated by this compound, and clustering analysis revealed that these effects resembled those in splicing factor 3b subunit 1 (SF3B1) K700E mutant cells but contrasted with those of the splicing inhibitor H3B‐8800. Additionally, a group of serine/arginine‐rich (SR) protein genes was identified as representatively affected, likely via modulation of poison exon inclusion. This finding could guide further analysis of the mode of action of these compounds on splicing, which could be valuable for developing drugs for diseases associated with splicing abnormalities.

Subjects

MeSH terms (MEDLINE)

ExonsRNA Splicing FactorsRNA SplicingMutationHumansPhosphoproteinsHEK293 CellsSerine-Arginine Splicing FactorsAlternative Splicing

Author keywords

SR proteinspoison exonpre‐mRNA splicingsplicing‐modulatory compoundstructure–activity relationship

Substances

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsSerine-Arginine Splicing Factors

Authors and institutions

  • Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Graduate School of Life Science, Hokkaido University, Sapporo, Japan.
  • Comparative Genomics Laboratory, National Institute of Genetics, Mishima, Shizuoka, Japan.

ORCID profiles: Hiroshi Maita

Funding

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science London

Cite

APA

Matsumaru, T., Iwamatsu, T., Ishigami, K., Inai, M., Kanto, W., Ishigaki, A., Toyoda, A., Shuto, S., Maenaka, K., Nakagawa, S., & Maita, H. (2024). Identification of BAY61 ‐3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70002

Vancouver

Matsumaru T, Iwamatsu T, Ishigami K, Inai M, Kanto W, Ishigaki A, et al. Identification of BAY61 ‐3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70002

BibTeX
@article{Matsumaru2024,
  author = {Matsumaru, Takanori and Iwamatsu, Toshiki and Ishigami, Kana and Inai, Makoto and Kanto, Wataru and Ishigaki, Ayumi and Toyoda, Atsushi and Shuto, Satoshi and Maenaka, Katsumi and Nakagawa, Shinichi and Maita, Hiroshi},
  title = {Identification of BAY61 ‐3606 Derivatives With Improved Activity in Splicing Modulation That Induces Inclusion of Cassette Exons Similar to the Splicing Factor 3B Subunit 1 Mutation},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.70002}
}
Start for free →